These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 791156)

  • 1. [Pharmacokinetic of glipentide (UR-661) by IV. administration on healthy and diabetic volunteers (author's transl)].
    Rimbau Barreras V; Uriach Marsal J; Pou Torelló JM
    Arch Farmacol Toxicol; 1976 Aug; 2(2):115-22. PubMed ID: 791156
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
    Calvet JM; Matarrodona M; Bordas R
    Rev Iber Endocrinol; 1974; 21(124):347-62. PubMed ID: 4453782
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inotropic effect of tolbutamide and glipentide in isolated guinea pig atria (author's transl)].
    Sánchez-Casals MS; Morell-Mestre J
    Rev Esp Fisiol; 1974 Dec; 30(4):273-6. PubMed ID: 4456482
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
    Pou Torelló JM; Vilaclara JM
    Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial with glypentide. Comparison with the hypoglycemic activity of other sulfonylurea compounds].
    López JM; Khoury G; Fernández RC; COBOS JM; Huelva JL
    Rev Iber Endocrinol; 1976; 23(134):181-96. PubMed ID: 778973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical trial with a new oral antidiabetic, gliclazid, in general practice (author's transl)].
    Villiger U
    Schweiz Rundsch Med Prax; 1982 Apr; 71(16):699-704. PubMed ID: 7050960
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
    Bour H; Denard Y; Plauchu M; Rathery M; Simonin R; Thervet F; Warembourg H
    Nouv Presse Med; 1974 Feb; 3(5):249-51. PubMed ID: 4819946
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetic behaviour of gliquidone (AR-DF 26), a new sulfonyl urea. Summary of the studies so far (author's transl)].
    Kopitar Z; Koss FW
    Arzneimittelforschung; 1975; 25(12):1933-8. PubMed ID: 1243665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diamicron].
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):343-9. PubMed ID: 4679568
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the multiple-dose kinetics of glibornuride in man (author's transl)].
    Dubach UC; Korn A; Raaflaub J
    Arzneimittelforschung; 1975; 25(12):1967-9. PubMed ID: 130138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glipizide: a 2d generation sulfonamide and new antidiabetic].
    Deuil R
    Nouv Presse Med; 1975 Feb; 4(7):500-1. PubMed ID: 1093131
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
    Ninni M; Castelletta L
    Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
    [No Abstract]   [Full Text] [Related]  

  • 15. Glypentide: a new hypoglycaemic agent.
    Morell J
    Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood sugar and plasma lipids in fasting diabetics and in metabolically healthy subjects (author's transl)].
    Hausmann L; Grüger E; Hänel V; Schubotz R; Schneider J; Kaffarnik H
    MMW Munch Med Wochenschr; 1974 Jan; 116(2):49-52. PubMed ID: 4205574
    [No Abstract]   [Full Text] [Related]  

  • 17. [Duration of effective hypoglycaemic action of glipizide given once daily (author's transl)].
    Azzopardi J; Campbell IW; Clarke BF; Duncan LJ
    Med Klin; 1975 Jul; 70(28-29):1214-8. PubMed ID: 809650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of Glipizide on the blood glucose and insulin in non-ketotic diabetes mellitus (author's transl)].
    Patsch W; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1976 Jan; 88(2):57-9. PubMed ID: 1258487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride].
    Herrlinger H; Dörfler H; Wolfram G; Zöllner N
    Verh Dtsch Ges Inn Med; 1971; 77():550-2. PubMed ID: 5155895
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacokinetic and distribution studies in rats and mice of 14C-brovanexine (author's transl)].
    Rimbau V; Torralba A
    Arch Farmacol Toxicol; 1978 Aug; 4(2):253-60. PubMed ID: 727838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.